RBC Capital Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $767
Thermo Fisher Is Maintained at Equal-Weight by Barclays
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $686 From $658
Barclays Maintains Thermo Fisher Scientific(TMO.US) With Hold Rating, Raises Target Price to $620
Redburn Atlantic Initiates Coverage On Thermo Fisher Scientific With Buy Rating, Announces Price Target of $680
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
loading...
...
CY90 : Major is Reit. wow
YOHO3318 OP CY90 : yeah, as REITs are required to distribute at least 90% of their income
Mr Pistachio : DBS is a divd ATM long term hold but your cost basis in the teens is best
YOHO3318 OP Mr Pistachio : waiting for it to pull back to collect more =)
Chilli Doggie : The anticipation for the rate cut had been dragged too long contributing to the uptrend. Could pullback or push even higher once announcement is made.
I’m just waiting for the hype to end before adding more REIT positions.
View more comments...